Table 3. Independent associations of six experimental factors with willingness to participate in a biobank project.
| Willingness to participatea | |||
|---|---|---|---|
| Experimental factors assessed in the two clinical vignettes | Odds ratio | 95% CI | P-value |
| Vignette 1 | |||
| Cancer-oriented consent (vs general consent) | 0.90 | 0.72–1.12 | 0.35 |
| Single review of the patient’s chart or individual health data (vs several reviews) | 1.35 | 1.09–1.68 | 0.007 |
| Genetic analyses on the biospecimens (vs blood protein analysis) | 1.11 | 0.89–1.38 | 0.35 |
| Vignette 2 | |||
| Oral swabbing (vs blood sample) | 1.35 | 1.09–1.67 | 0.007 |
| No follow-up of patients (vs follow-up) | 1.54 | 1.24–1.91 | <0.001 |
| Local project (vs international) | 0.88 | 0.71–1.10 | 0.27 |
Abbreviation: CI, confidence interval.
Obtained by ordinal logistic regression model. Willingness to participate was rated on a 5-point Likert scale.